MV BioTherapeutics ApyraMed

Technology

The ApyraMed technology exploits a recombinant live biotherapeutic that promotes adaptive intestinal homeostasis. In cancer patients, it enhances immune system competence, whereas in dysbiosis safeguards the intestinal ecosystem.

MV BioTherapeutics ApyraMed